How industry and the NHS can work together to bridge the diagnostic gap in COPD
Mind the gap
Related Posts
Oxford Brain Diagnostics to launch groundbreaking dementia diagnosis technology
Company secures regulatory approvals for commercial rollout in UK and US With over 55 million […]
Jessica Atkinson – PharmaTimes
VectorY Therapeutics has appointed Jessica Atkinson as Chief Business Officer VectorY Therapeutics has appointed Jessica Atkinson as Chief Business Officer. In […]
UK sees 70% increase in phase I advanced therapy clinical trials in 2024
Cell and Gene Therapy Catapult reveals significant growth in UK trials The UK experienced a […]